EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Exploring Preeclampsia: A Comprehensive Overview

Maheen Nasir, Aimen Binte Asif, Momnah Waheed, Javeria Irfan, Qudsia Umaira Khan, Ayra Waseem

Discoveries · 30.09.2025 · 13 (3) · e214

DOI: 10.15190/d.2025.13 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Discoveries, online erschienen am 30.09.2025. Verfasst von Maheen Nasir und 5 weiteren Autor:innen. Beteiligte Einrichtung: CMH Lahore Medical and Dental College, Pakistan. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Preeclampsia remains a significant complication of pregnancy which emerges after the 20th week mark and is identified by proteinuria and hypertension. This review explores the multifaceted nature of preeclampsia, beginning with its complex pathology involving endothelial, platelet dysfunction and the imbalance in the factors that regulate angiogenesis. Diagnosis relies on monitoring blood pressure and assessing proteinuria, supported by laboratory tests and imaging studies to detect organ involvement. Biomarkers including Soluble fms-like tyrosine kinase (sFlt-1) and placental growth factor (PlGF) play a critical role in early detection and risk stratification. The imbalance in the ratio between these two biomarkers serves as a key in diagnosing and predicting preeclampsia. Vascular homeostasis is upset by this imbalance, which results in clinical symptoms such as hypertension and urinary protein excretion. Elevated sFlt-1 and reduced PlGF in high-risk pregnancies, including those with chronic hypertension, correlate with greater clinical severity and predict adverse outcomes for maternal and fetal health. Management strategies include the use of antihypertensive medicines, fetal monitoring and delivery of the fetus based on disease severity. Despite ongoing research into predictive biomarkers and preventative measures, preeclampsia remains a challenge and necessitates a multidisciplinary approach for the well-being of both the fetus and the mother. This review serves as a comprehensive resource for clinicians and healthcare workers and by consolidating current knowledge and practical approaches allows them to stay updated on the evolving role of biomarkers in improving diagnostic accuracy.

Schlagwörter

Stichwörter der Autor:innen

biomarkersplacenta.placental growth factorpreeclampsiasoluble fms-like tyrosine kinase

Autor:innen und Institutionen

  • CMH Lahore Medical and Dental College, Pakistan.
  • Learning Alliance, Pakistan.

Zitieren

APA

Nasir, M., Asif, A. B., Waheed, M., Irfan, J., Khan, Q. U., & Waseem, A. (2025). Exploring Preeclampsia: A Comprehensive Overview. Discoveries, 13(3), e214. https://doi.org/10.15190/d.2025.13

Vancouver

Nasir M, Asif AB, Waheed M, Irfan J, Khan QU, Waseem A. Exploring Preeclampsia: A Comprehensive Overview. Discoveries. 2025;13(3):e214. doi:10.15190/d.2025.13

BibTeX
@article{Nasir2025,
  author = {Nasir, Maheen and Asif, Aimen Binte and Waheed, Momnah and Irfan, Javeria and Khan, Qudsia Umaira and Waseem, Ayra},
  title = {Exploring Preeclampsia: A Comprehensive Overview},
  journal = {Discoveries},
  year = {2025},
  volume = {13},
  number = {3},
  pages = {e214},
  doi = {10.15190/d.2025.13}
}
Kostenlos starten →